Transglutaminase (TGase) has been implicated in maintaining the undifferentiated stage of hematopoietic stem cells (HSC) in the crayfish Pacifastacus leniusculus. TGase activity has been reported to be regulated by astakine1, an essential crayfish cytokine for inducing new hemocyte synthesis in hematopoietic tissue (HPT). Here, the role of astakine1 in TGase activity regulation and clotting protein (CP) cross-linking was characterized. A reduction in TGase activity was observed by the addition of purified astakine1 in vitro for both endogenous crayfish TGase and a commercial purified guinea pig liver TGase. As a result, we observed that astakine1 inhibits TGase enzyme activity and acts as a non-competitive inhibitor for the TGase enzyme. Additionally, the clotting reaction was impaired in the presence of astakine1. A decrease in TGase-mediated crosslinking of ε(g-glutamyl)-lysine bonds was also observed in the presence of astakine1. In conclusion, this study shows that astakine1 acts as an inhibitor of TGase activity and that it also affects CP cross-linking during crayfish hematopoiesis.
Introduction
Invertebrates, including crustaceans, rely on innate immunity because they lack adaptive immunity. In crayfish, blood cells or hemocytes are important cellular mediators of immune reactions, such as phagocytosis and encapsulation, and they also contain immune components, such as the prophenoloxidase (proPO)-activating melanization cascade. (Cerenius et al., 2008; Jiravanichpaisal et al., 2006) . Thus, the hemocyte number and its regulation are crucial for the animal to be able to defend itself. Hemocytes are produced and released into circulation, and this process is termed 'hematopoiesis'.
To study the molecules involved in hematopoiesis, using an in vitro culture system, the crayfish hematopoietic cytokine, astakine1, was identified (S€ oderh€ all et al., 2005) . Astakine1 was purified from plasma, and the plasma levels of astakine1 could be increased with LPS stimulation. Crayfish injected with a native purified astakine1 had an increased total number of circulating hemocytes (S€ oderh€ all et al., 2005) , and astakine1 was shown to be essential to stimulate proliferation and differentiation of HPT cells, specifically in the semi-granular cell lineage (Lin et al., 2010) . Astakine1 can also reduce apoptosis in HPT cells by affecting the transcription of crustacean hematopoietic factor (CHF) in HPT cells .
These studies all show that astakine1 plays a regulating role at the crossroads between proliferation/differentiation and apoptosis.
Transglutaminase (TGase) is an abundant protein in the HPT cells of crayfish, and its activity has been determined in the hematopoietic tissue (Lin et al., 2008) . TGase activity was low in HPT cells that were migrating out of the tissue in culture, in contrast to cells at the tissue center. This study suggested that TGase plays a role in maintaining the undifferentiated stage of HPT cells inside the tissue (Lin et al., 2008) . However, the role of astakine1 in TGase regulation is still unclear. High expression of clotting protein (CP) was found in crayfish HPT tissue in a transcriptome analysis (BioProject ID: PRJNA259594). CP is a well-known TGase substrate, in addition to collagen IV (Hall et al., 1999; Junkunlo et al., 2016) . Crayfish CP is known to be involved in hemolymph clot formation (Wang et al., 2001) . In osteoblast cell cultures, TGase activity was reported to be essential for the initial formation of the fibronectincollagen network, which subsequently affected cell differentiation and mineralization in MC3T3-E1 osteoblast cultures (Al-Jallad et al., 2006) . TGase activity is important for extracellular matrix (ECM) stabilization, and a decrease in its extracellular activity causes hemocyte release from HPT (Lin et al., 2008) .
This study aimed to i) identify the role of astakine1 in regulating TGase activity and ii) show how astakine1 regulation of TGase activity affects the clotting process.
Materials and methods

Experimental animals
Freshwater crayfish (P. leniusculus) were obtained from Lake Erken (Sweden). Intermolt and healthy crayfish were maintained in aerated aquaria at 10 C and used for the experiments.
Astakine1 purification from plasma
Hemolymph was collected from 15 to 20 crayfish and then centrifuged at 3000Âg for 5 min to spin down the hemocytes, and the cell-free plasma supernatant was collected. The pooled plasma supernatant was diluted with 20 mM Hepes and 150 mM NaCl (V: V ¼ 1:1) and then supplemented with trifluoroacetic acid (TFA, Merck) to a final concentration of 0.5%. The diluted plasma was centrifuged at 8000Âg for 20 min at 4 C to remove precipitate, followed by filtration through a 0.45 mm filter. The resulting plasma was subjected to a small single-use sep-pak C18 cartridge (Waters) pre-equilibrated with 100% acetonitrile, followed by 20 ml of wash buffer (10 mM Hepes, 150 mM NaCl, and 0.5% TFA). The plasma was passed through the sep-pak column twice and washed with 50 ml wash buffer. Bound proteins were eluted stepwise with wash buffer containing 10%e100% acetonitrile. The 50% acetonitrile eluted fractions were aliquoted and vacuum-dried. The dried pellet was stored at À80 C and suspended with L-15 medium before use.
Transglutaminase enzyme preparation
To prepare endogenous TGase, HPT cells were freshly isolated, as described previously (Lin et al., 2008) . The cells were then homogenized in 100 ml RIPA buffer (50 mM Tris, 150 mM NaCl, 10 mM EDTA, 1% IGEPAL, 1% SDS, pH 7.5) containing 10 times diluted protease inhibitor cocktail (Roche) from the recommed stock solution (10X). After centrifugation of the homogenate at 13,000Âg for 15 min at 4 C, the protein supernatant was immediately used in a TGase inhibition assay. The protein concentration was determined by using Coomassie Plus protein assay reagent (Thermo Scientific).
Guinea pig liver TGase
Lyophilized Guinea pig liver TGase (T5398) powder was purchased from Sigma and dissolved in 1 ml dH 2 O as an enzyme stock solution. 1 U of commercial purified TGase was freshly prepared in buffer A (50 mM Tris-HCl, 0.15 M NaCl, pH 8.0) before use in the experiments.
Transglutaminase activity assay
The TGase activity was assayed by using a modified nonradioactive microtiter plate (Slaughter et al., 1992) . Briefly, the microtiter plate was coated with 100 ml of N,N'-dimethylcasein (Sigma, 10 mg/ml) at 4 C overnight. After blocking with blocking solution (0.5% BSA in 0.1 M Tris-HCl, pH 8.5) for 30 min at room temperature, the wells were washed three times with 0.1 M TrisHCl, pH 8.5. The incubation mixture, which contained 5 mM CaCl 2 , 10 mM dithiothreitol, 0.1 mM of 5-(biotinamido) pentylamine substrate, 10 mg protein of whole cell lysates and 0.1 M TrisHCl, pH 8.5, was added to obtain a total volume of 200 ml per well.
After incubation at 37 C for 30 min, the reaction was stopped by washing twice with 200 mM EDTA, followed by washing three times with 0.1 M Tris-HCl, pH 8.5. Streptavidin-horseradish peroxidase conjugate (GE Healthcare) was diluted to 1:1000 in blocking solution before it was added to the wells for a 1 h incubation at room temperature. The plate was washed once with 0.01% Triton X-100, followed by five washes with 0.1 M Tris-HCl, pH 8.5.
Then, 50 ml of 3,3 0 ,5,5 0 -Tetramethylbenzidine substrate solution (TMB, Sigma) was added to each well. After incubation for 10 min at room temperature, the reactions were stopped by the addition of 50 ml of 3 N HCl to each well. The TGase cross-linking activity in which 5'-(biotinamido) pentylamine was incorporated into N,N'-dimethylcasein was quantified by measuring the absorbance at 450 nm in a plate reader (Molecular Device).
To examine the temperature dependence of the endogenous crayfish TGase enzyme, samples of whole cell lysate (10 mg protein/ well) were tested at different temperatures, including 4, 16, 25 and 37 C.
Transglutaminase inhibition assay
All kinetic and inhibition experiments were performed by using a modified non-radioactive microtiter plate, as described above. The reaction mixture consisted of four concentrations of 5-(biotinamido) pentylamine substrate (0.012, 0.025, 0.05 and 0.1 mM) in the presence of a fixed amount of commercial Guinea pig TGase (dilution 1:1000 in 0.1 M Tris-HCl, pH 8.5) and three different concentrations of purified native astakine1 (0.2, 0.4 and 0.6 mM).
The optical density represents enzyme activity and is plotted against the molar ratio of astakine1.
Purification of clotting protein (CP) from crayfish plasma
Crayfish hemolymph from 9 crayfish (approximately 15 ml) was removed and placed into 15 ml ice-cold anti-coagulant buffer (0.14 M NaCl, 0.1 M glucose, 30 mM trisodium citrate, 26 mM citric acid, pH 4.6) (Kop a cek et al., 1993). The hemocyte pellets were removed by centrifugation at 800Âg, 10 min at 4 C. Then, the plasma was further dialyzed (Spectra/Por, 6e8 MWCO) towards 10 mM sodium phosphate pH 6.0 containing 1 mM EDTA overnight at 4 C. After centrifugation of the dialyzed plasma at 2500Âg, 10 min at 4 C, the precipitated orange colored CP pellets were obtained and re-suspended in 500 ml 0.2 M sodium phosphate, pH 6.0, containing 1 mM EDTA. The resulting supernatant was collected as CP-depleted plasma and used as a control in the clotting assay. The purity of clotting protein was analyzed by 7.5% SDS-PAGE and compared with CP-depleted plasma and crayfish plasma.
The clotting assay
Crayfish plasma (10 mg protein/ml), CP-depleted plasma (10 mg protein/ml), and purified CP (10 mg protein/ml) samples were dialyzed separately overnight against buffer A. The clotting assay was tested in tubes with or without astakine1 (0.6 mM). Plasma for re-suspending astakine1 was used as a control sample. Five different samples were mixed as follows: (1) 20 ml CP þ 390 ml buffer A þ 25 ml plasma; (2) 400 ml CP-depleted plasma þ10 ml buffer A þ 25 ml plasma; (3) 20 ml CP þ 390 ml buffer A þ 25 ml astakine1; (4) 400 ml CP-depleted plasma þ10 ml buffer A þ 25 ml astakine1 and (5) 400 ml crayfish plasma þ10 ml buffer A þ 25 ml plasma. All test tube samples received aliquots of 50 ml of 1 U commercial TGase and 15 ml of 1 M CaCl 2 (in buffer A). After incubation for 3 h at room temperature, the tubes were tilted and laid down observe clot formation.
TGase-mediated crosslinking assay
The experiments were performed based on CP polymerization, as reported previously (Kop a cek et al., 1993) . Briefly, 5 ml of purified CP (2 mg protein/ml) was tested in the presence or absence of astakine1 (0.6 mM). CP-depleted plasma samples (2 mg protein/ml) were used as controls. Five microliters of 1 U commercial purified TGase and 5 ml of 0.12 M CaCl 2 (in buffer A) were added to each tube. After incubation at 37 C for 3 h, the reaction was terminated with 1 ml of 0.2 M EDTA, followed by western blotting. The different samples were mixed with protein loading buffer (Laemmli sample buffer, 62.5 mM Tris-HCl, 2% SDS, 10% (v/v) glycerol, 0.1 M DTT and 0.01% bromophenol blue, pH 6.8), separated using 7% SDS-PAGE and then electro-transferred onto a polyvinylidene fluoride membrane (PVDF) (GE Healthcare) for 2 h. The blot was blocked in 10% skim milk blocking buffer in PBS-T (0.5% tween-20 in 1 Â PBS buffer, pH 7.4) for 1 h at room temperature. The membrane was incubated with anti-ε(g-glutamyl)-lysine monoclonal antibody at a 1:500 dilution (ab424, Abcam) in blocking buffer at 4 C overnight. After extensive washing, the membrane was incubated with antimouse antibody conjugated with horseradish peroxidase (GE Healthcare) at a 1:1000 dilution. The signal detection was performed by using Clarity western ECL substrate (Bio-Rad) according to the manufacturer's instructions.
Results
Astakine1 inhibits TGase enzymatic activity
To determine the effect of astakine1 on TGase-mediated crosslinking activity, purified native astakine1 from crayfish plasma was added to a TGase activity assay reaction mixture. This was investigated by using a modified non-radioactive microtiter plate test to show if purified astakine1 could compete with TGase-mediated 5-(biotinamido)-pentylamine (BPHN 2 ) incorporation. BPNH 2 is a conjugated biotin primary amine, which is covalently incorporated into N,N'-dimethylcasein by TGase enzyme activity. To better understand the role of astakine1 in TGase activity regulation, a purified commercial Guinea pig liver TGase was also used for comparison with the crayfish TGase. Regarding the temperature dependence of the endogenous TGase, we found that there was no significant difference in the TGase activities at 16, 25 and 37 C (Fig. 1) and there was significant activity also at 4 C. Then, TGase activity inhibition was further tested at 37 C with different concentrations of astakine1 (from 0.2 to 0.6 mM) for native endogenous and commercial TGase. The results show that by increasing the astakine1 concentration, the TGase enzyme activity was decreased (Fig. 2) . The highest astakine1 concentration, 0.6 mM, resulted in a remaining activity of 24% for the endogenous TGase compared with the control (Fig. 2A) . The same astakine1 concentration was reduced to a residual activity of 50% for the commercial TGase enzyme when compared with the control (Fig. 2B ). This result shows that astakine1 inhibited the TGase activity.
Astakine1 acts as a non-competitive inhibitor for TGase activity
To investigate the kinetics of the inhibition experiments, commercial TGase and varying concentrations of the substrate and astakine1 were evaluated. The obtained data were analyzed by using GraphPad Prism with non-linear regression analysis, and a Michaelis-Menten kinetics graph was constructed (Fig. 3) . We found that astakine1 seemed to act as a non-competitive inhibitor, as the inhibition was not decreased when the substrate concentration was increased.
Reduced clotting reaction activity by astakine1
To test whether TGase activity inhibition by astakine1 could affect the clotting reaction, the ability for TGase to catalyze CP cross-linking in a gel formation assay was evaluated. The clotting reaction was supplemented with commercial TGase and Ca 2þ in the mixture. The clotting ability is shown in Table 1 . The non-dialyzed plasma samples provided the most obvious clot formation. The purified CP showed a nearly identical clotting ability as that of the plasma, while the CP-depleted plasma had low or no clot formation. However, the clotting ability of the purified CP was clearly reduced when supplemented with astakine1 (Table 1 ). This result indicates that astakine1 can also interfere with TGase-mediated CP crosslinking.
Astakine1 affects TGase-mediated crosslinking activity
In crayfish, it is known that CP can be used by TGase enzymes for cross-linking during hemolymph gel formation (Kop a cek et al., 1993; Hall et al., 1999) . CP is highly expressed in HPT tissue, and therefore, we intended to clarify whether impaired-TGase activity could impact CP crosslinking by including astakine1 in the reaction. We tested if astakine1 could inhibit the TGase enzyme crosslinking activity by incubation of purified CP with or without astakine1 in the presence of commercial TGase and Ca 2þ . CP-depleted plasma was used as a negative control. Western blot analysis revealed a high molecular weight signal (>250 kDa) in the sample with purified CP without astakine1, while this band was not detected in the CP-depleted plasma (Fig. 4) . A low amount of cross-linking at the high molecular weight (>250 kDa) was observed in the purified CP sample when astakine1 was added. This suggests that astakine1 can inhibit the TGase-mediated crosslinking reaction (Fig. 4) .
Discussion
The production and renewal of hemocytes occur in the hematopoietic tissue, and this process is tightly regulated to control and balance hemocyte numbers in the circulatory system. Astakine1 and TGase have been determined as important factors in blood cell differentiation/proliferation in freshwater crayfish (Lin et al., 2008; S€ oderh€ all et al., 2005; S€ oderh€ all, 2016) . Astakine1 is a homologue of vertebrate prokineticins, endocrine gland-derived vascular endothelial growth factor (EG-VEGF)/PK1 and Bv8/PK2. They are involved in several physiological functions, such as angiogenesis, neurogenesis and circadian rhythms (Monnier and Samson, 2008; Negri et al., 2007) . Vertebrate prokineticins are known to be involved in hematopoiesis by promoting differentiation and mobilization of granulocyte and monocyte lineage cells (Dorsch et al., 2005; LeCouter et al., 2004) . In crayfish, astakine1 is known as a hematopoietic growth factor, and it especially stimulates the differentiation of the SGC hemocyte lineage (Lin et al., 2010) . Crayfish TGase from hemocytes catalyzes the clotting process, which depends on the TGase-mediated crosslinking of plasma CP (Kop a cek et al., 1993) . However, a function of TGase in HPT tissue has been shown where it stabilizes the matrix and maintains HPT cells in an undifferentiated stage (Lin et al., 2008) . Here, we show a function of astakine1 in TGase activity regulation in vitro. We show that astakine1 can inhibit TGase activity in a dose-dependent manner. Endogenous TGase is a crude enzyme source that is prepared from HPT lysate, which means that others proteins were present in the inhibition assay reaction. However, it is important to note that TGase is very abundant in HPT cells and accounts for 40e50% of the total protein concentration (Lin et al., 2008) . Astakine1 seems to act as a non-competitive inhibitor of TGase activity (Fig. 3) . Interestingly, endogenous TGase functioned over a wide range of temperatures. The freshwater crayfish P. leniusculus normally lives in a wide range of habitats but generally prefers cold water. Therefore, the observation that the optimum temperature for TGase has a very broad range, from 16 C to 37 C, and that it was still active at 4 C may be a possible adaptation of this animal.
In shrimp, TGase and crustin have been reported as RNAbinding proteins to the 3 0 -UTR of astakine, and a reduction of TGase and crustin by siRNA increased the protein level of astakine, while the astakine mRNA level remained unchanged (Chang et al., 2013) . In this study, we showed that astakine1 regulates TGase at the protein level by inhibiting TGase activity. Additionally, after prolonged culture of HPT cells with plasma containing astakine1, the extracellular TGase activity was decreased. When the TGase mRNA expression was decreased with dsRNAi, the HPT cells started to intensely spread (Lin et al., 2008) . This indicates that extracellular TGase is involved in extracellular matrix (ECM) interactions in order to maintain the HPT tissue microenvironment and to suppress stem cell differentiation. TGase is well known for playing a role in ECM protein crosslinking (Belkin, 2011) , and TGase activity is crucial for cellular matrix stabilization and cell differentiation/ proliferation (Li et al., 2015; Myneni et al., 2014) . Type IV collagen has been characterized as an ECM protein in crayfish, and it was found to be co-localized with TGase on the surface of HPT cells (Junkunlo et al., 2016) . Interestingly, CP mRNA expression is high in HPT, and therefore, it is likely that CP could be an ECM protein in HPT tissue. Moreover, the CP subunits contain both glutamine and lysine residues that are available for crosslinking by TGase (Hall et al., 1999) . To reveal how astakine1 regulates TGase and CP and their clotting formation, we first observed the clotting reactions with purified CP and TGase with or without astakine1. The results showed that astakine1 decreased clot formation in the presence of purified CP and TGase. Additionally, we also confirmed the TGasemediated crosslinking reaction and CP polymerization by determining the ε(g-glutamyl)-lysine bond level. The result showed a stronger crosslinking bond signal in the purified CP when astakine1 was deprived, while purified CP that included astakine1 showed lower signal levels in the western blot results. This clearly indicates a role for CP in hematopoiesis. That astakine1 is affecting clot formation by inhibiting TGase enzyme activity and not only induce a higher hemocyte synthesis is logic since clot formation during wound healing should be a highly localized response. During wounding hemocytes are attracted to the wound site to release TGase enzyme and after some clotting has occurred at the wound site this process must be stopped to avoid a total clot formation in the hemolymph. This process is similar to that occurring with control of melanization, where the activating protease is rapidly degraded to avoid unwanted melanization. In addition, there are inhibitors in plasma such as pacifastin to inhibit the activating protease and if phenoloxidase is still active the melanization inhibiting protein (MIP9) will also aid in control of melanization so it only occurs locally (Asp an et al., 1990; Liang et al., 1997; S€ oderh€ all et al., 2009) .
Conclusion
In summary, the function of astakine1 in regulating TGase activity was studied. Astakine1 could inhibit crayfish and rodent TGase enzymatic crosslinking activity. Moreover, we showed that astakine1 seems to act as a non-competitive inhibitor. The inhibitory activity of astakine1 also led to impaired TGase-mediated crosslinking of the purified clotting protein. Table 1 Clotting formation of purified clotting protein in the presence or absence astakine1. Semi-quantitative determination where þþþþ means a complete clot formation and 0 means low or no clot formation. A representative picture from one of four experiments is included.
Sample
Clotting Fig. 4 . A TGase activity assay shows ε(g-glutamyl)-lysine bond formation by TGasemediated CP cross-linking. Western blot results are shown with an anti-ε(g-glutamyl)-lysine monoclonal antibody at a 1:500 dilution (Abcam). This experiment was repeated three times with similar results.
